Ellis Andrea
Director at BBIO
- Sold, on record
- $7.9M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jul 9, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BBIOBridgeBio Pharma, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BBIORoutineApr 1 2025
Sold 30,000 shares at $34.05 ($1M)
Ellis Andrea, Director
10b5-1 planSold 71.4% of holdings ($1.4M position)12,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale BBIORoutineApr 14 +13 days
Sold 10,000 shares at $35.00 ($350k)
Ellis Andrea, Director
10b5-1 planSold 45.5% of holdings ($770k position)12,000 shares leftFiling
- 3 Form 4 sale BBIORoutineAug 5 +113 days
Sold 17,167 shares at $49.00 ($841k)
Ellis Andrea, Director
10b5-1 planSold 48% of holdings ($1.8M position)18,589 shares leftFiling
- 4 Form 4 sale BBIOUnusualMar 4 +211 days
Sold 64,921 shares at $64.87 ($4.2M)
Ellis Andrea, Director
10b5-1 planSold 77.7% of holdings ($5.4M position)18,589 shares left3.8x usual sizeFiling
- 5 Form 4 sale BBIORoutineJul 9 +127 days
Sold 17,167 shares at $84.00 ($1.4M)
Ellis Andrea, Director
10b5-1 planSold 43.2% of holdings ($3.3M position)22,579 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | BBIO | Director | Form 4 sale | 17,167 | $1.4M | 43.2% | Routine | SEC |
| Mar 4, 2026 | BBIO | Director | Form 4 sale | 64,921 | $4.2M | 77.7% | Unusual | SEC |
| Aug 5, 2025 | BBIO | Director | Form 4 sale | 17,167 | $841k | 48.0% | Routine | SEC |
| Apr 14, 2025 | BBIO | Director | Form 4 sale | 10,000 | $350k | 45.5% | Routine | SEC |
| Apr 1, 2025 | BBIO | Director | Form 4 sale | 30,000 | $1M | 71.4% | Routine | SEC |